Trial intelligence / Profile preview

BARIFER: Liposomated Iron vs Intravenous Iron in Post-Bariatric Surgery Patients

NCT02390921Phase 4Completed

Sponsor
Vall d'Hebron Research Institute
Start
Feb 2015
Primary completion
Oct 2015
Modality
Lipid-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ferric pyrophosphate liposomal in iron deficiency anemia (IDA), sponsored by Vall d'Hebron Research Institute. Started Feb 2015; status: completed.

02

Drugs

ferric pyrophosphate liposomal
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT02390921.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02390921.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call